abstract |
The invention concerns a hybridome called 5C5 (CNCM n° I-2184) and the monoclonal antibody 5C5 which it produces. Said monoclonal antibody which specifically recognises most human renal cell carcinomas, is developed for diagnosing, imaging and treating human renal cell carcinomas. |